135 related articles for article (PubMed ID: 201214)
1. Polymyxin B and rifampin: new regimen for multiresistant Serratia marcescens infections.
Ostenson RC; Fields BT; Nolan CM
Antimicrob Agents Chemother; 1977 Dec; 12(6):655-9. PubMed ID: 201214
[TBL] [Abstract][Full Text] [Related]
2. Failure of polymyxin B nonapeptide to augment bactericidal activities of novobiocin, rifampin, and of defibrinated human blood against Serratia marcescens.
Traub WH; Kohl KH; Spohr M; Bauer D
Chemotherapy; 1988; 34(3):195-201. PubMed ID: 2843325
[TBL] [Abstract][Full Text] [Related]
3. In vitro additive effect of polymxin B and rifampin against Serratia marcesen.
Traub WH; Kleber I
Antimicrob Agents Chemother; 1975 Jun; 7(6):874-6. PubMed ID: 168807
[TBL] [Abstract][Full Text] [Related]
4. Reliability of the colistin disk test in identification of Serratia marcescens and Serratia liquefaciens.
von Graevenitz A; Zollinger-Iten J
Eur J Clin Microbiol; 1987 Feb; 6(1):70-1. PubMed ID: 3032610
[TBL] [Abstract][Full Text] [Related]
5. Localization of polysaccharide components in polymyxin B treated cells of Serratia marcescens.
Weber DA; Nadakavukaren MJ; Tsang JC
J Antibiot (Tokyo); 1978 Jul; 31(7):732-5. PubMed ID: 211111
[No Abstract] [Full Text] [Related]
6. In vitro activity of polymyxin B plus imipenem, meropenem, or tigecycline against KPC-2-producing Enterobacteriaceae with high MICs for these antimicrobials.
Barth N; Ribeiro VB; Zavascki AP
Antimicrob Agents Chemother; 2015; 59(6):3596-7. PubMed ID: 25801560
[TBL] [Abstract][Full Text] [Related]
7. Polymyxin B-induced cocarde growth phenomenon of Serratia marcescens due to cationic detergent-like activity of polymyxin B.
Traub WH
Chemotherapy; 1982; 28(5):363-8. PubMed ID: 6291867
[TBL] [Abstract][Full Text] [Related]
8. Electron microscopic observations of polysaccharide components in polymyxin B treated outer membranes from Serratia marcescens.
Weber DA; Nadakavukaren MJ; Tsang JC
J Antibiot (Tokyo); 1979 Jan; 32(1):66-72. PubMed ID: 83989
[TBL] [Abstract][Full Text] [Related]
9. Chemical and electrophoretic changes induced by polymyxin B on outer membrane components from Serratia marcescens.
Brown DA; Tsang JC
J Antibiot (Tokyo); 1978 Jun; 31(6):603-9. PubMed ID: 210151
[TBL] [Abstract][Full Text] [Related]
10. In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii.
Yoon J; Urban C; Terzian C; Mariano N; Rahal JJ
Antimicrob Agents Chemother; 2004 Mar; 48(3):753-7. PubMed ID: 14982760
[TBL] [Abstract][Full Text] [Related]
11. Effect of polymyxin B on the synthesis of prodigiosin and its precursors in Serratia marcescens.
Tsang JC; Feng JS
J Antibiot (Tokyo); 1983 Nov; 36(11):1564-6. PubMed ID: 6317625
[No Abstract] [Full Text] [Related]
12. In vivo potentiation of the action of polymyxin B by gramicidin Dubos.
Radhakrishna G; Ramachandran LK
Indian J Exp Biol; 1981 Jan; 19(1):57-60. PubMed ID: 6165682
[No Abstract] [Full Text] [Related]
13. Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City.
Quale J; Shah N; Kelly P; Babu E; Backer M; Rosas-Garcia G; Salamera J; George A; Bratu S; Landman D
Microb Drug Resist; 2012 Apr; 18(2):132-6. PubMed ID: 22196342
[TBL] [Abstract][Full Text] [Related]
14. Effect of polymyxin B on outer membranes of Serratia marcescens: morphological alterations of the outer membranes and their lipopolysaccharide components.
Weber DA; Nadakavukaren MJ; Tsang JC
Microbios; 1976; 17(68-69):149-61. PubMed ID: 200827
[TBL] [Abstract][Full Text] [Related]
15. Effect of polymyxin B on kappa phage adsorption on Serratia marcescens HY.
Patel KA; Patel IR; Mehta AM; Dave PJ
Indian J Exp Biol; 1980 Nov; 18(11):1353-4. PubMed ID: 6260637
[No Abstract] [Full Text] [Related]
16. Enhancement by polymyxin B of proline-induced prodigiosin biosynthesis in non-proliferating cells of Serratia marcescens.
Lauferska U; Viñas M; Lorén JG; Guinea J
Microbiologica; 1983 Apr; 6(2):155-62. PubMed ID: 6306401
[No Abstract] [Full Text] [Related]
17. Serratia marcescens arn, a PhoP-regulated locus necessary for polymyxin B resistance.
Lin QY; Tsai YL; Liu MC; Lin WC; Hsueh PR; Liaw SJ
Antimicrob Agents Chemother; 2014 Sep; 58(9):5181-90. PubMed ID: 24957827
[TBL] [Abstract][Full Text] [Related]
18. Genotypic characterization and in vitro activities of tigecycline and polymyxin B for members of the Enterobacteriaceae with decreased susceptibility to carbapenems.
Zhang R; Cai JC; Zhou HW; Nasu M; Chen GX
J Med Microbiol; 2011 Dec; 60(Pt 12):1813-1819. PubMed ID: 21835972
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of a synergistic combination of cefotaxime and amikacin against multiresistant Pseudomonas and Serratia infections.
Maslow MJ; Simberkoff MS; Rahal JJ
J Antimicrob Chemother; 1985 Aug; 16(2):227-34. PubMed ID: 3934125
[TBL] [Abstract][Full Text] [Related]
20. Synergy of imipenem--a novel carbapenem, and rifampin and ciprofloxacin against Pseudomonas aeruginosa, Serratia marcescens and Enterobacter species.
Chin NX; Neu HC
Chemotherapy; 1987; 33(3):183-8. PubMed ID: 3109815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
